GeoVax Labs Future Growth
Future criteria checks 5/6
GeoVax Labs is forecast to grow earnings and revenue by 65.9% and 67.9% per annum respectively while EPS is expected to grow by 73.6% per annum.
Key information
65.9%
Earnings growth rate
73.6%
EPS growth rate
Biotechs earnings growth | 28.3% |
Revenue growth rate | 67.9% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 20 Nov 2024 |
Recent future growth updates
Recent updates
We Think GeoVax Labs (NASDAQ:GOVX) Needs To Drive Business Growth Carefully
Sep 08GeoVax: Possible Vaccine Advancements In 2 Big Indications
Aug 08GeoVax adds 16% as journal publishes animal study on ebolavirus vaccine
Jul 28Companies Like GeoVax Labs (NASDAQ:GOVX) Could Be Quite Risky
May 24GeoVax: A Legitimate COVID-19 Phase 2 Vaccine Candidate Trading At Only A $25 Million Valuation
Dec 27We Think GeoVax Labs (NASDAQ:GOVX) Can Afford To Drive Business Growth
Nov 27GeoVax: Expands Immuno-Oncology Pipeline With Clinical-Stage Program
Oct 03We Think GeoVax Labs (NASDAQ:GOVX) Can Afford To Drive Business Growth
Aug 14Did Business Growth Power GeoVax Labs' (NASDAQ:GOVX) Share Price Gain of 111%?
Feb 18GeoVax soars on NIAID grant for COVID-19 vaccine candidate
Jan 11Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 6 | -21 | -16 | -17 | 3 |
12/31/2025 | 14 | -15 | -17 | -17 | 5 |
12/31/2024 | 5 | -23 | -21 | -19 | 4 |
9/30/2024 | 3 | -24 | -27 | -27 | N/A |
6/30/2024 | 0 | -27 | -23 | -23 | N/A |
3/31/2024 | N/A | -28 | -27 | -27 | N/A |
12/31/2023 | N/A | -26 | -25 | -25 | N/A |
9/30/2023 | N/A | -24 | -22 | -22 | N/A |
6/30/2023 | N/A | -19 | -21 | -21 | N/A |
3/31/2023 | N/A | -16 | -19 | -18 | N/A |
12/31/2022 | 0 | -14 | -19 | -19 | N/A |
9/30/2022 | 0 | -22 | -19 | -19 | N/A |
6/30/2022 | 0 | -20 | -17 | -16 | N/A |
3/31/2022 | 0 | -19 | -14 | -14 | N/A |
12/31/2021 | 0 | -19 | -11 | -11 | N/A |
9/30/2021 | 0 | -6 | -6 | -6 | N/A |
6/30/2021 | 1 | -5 | -5 | -5 | N/A |
3/31/2021 | 1 | -4 | -4 | -4 | N/A |
12/31/2020 | 2 | -3 | -3 | -3 | N/A |
9/30/2020 | 2 | -2 | -1 | -1 | N/A |
6/30/2020 | 2 | -2 | -2 | -2 | N/A |
3/31/2020 | 2 | -2 | -1 | -1 | N/A |
12/31/2019 | 1 | -2 | -1 | -1 | N/A |
9/30/2019 | 1 | -2 | -2 | -2 | N/A |
6/30/2019 | 1 | -3 | -2 | -2 | N/A |
3/31/2019 | 1 | -3 | -1 | -1 | N/A |
12/31/2018 | 1 | -3 | -2 | -2 | N/A |
9/30/2018 | 1 | -2 | -1 | -1 | N/A |
6/30/2018 | 1 | -2 | N/A | -2 | N/A |
3/31/2018 | 1 | -2 | N/A | -2 | N/A |
12/31/2017 | 1 | -2 | N/A | -2 | N/A |
9/30/2017 | 1 | -3 | N/A | -2 | N/A |
6/30/2017 | 1 | -2 | N/A | -2 | N/A |
3/31/2017 | 1 | -3 | N/A | -2 | N/A |
12/31/2016 | 1 | -3 | N/A | -2 | N/A |
9/30/2016 | 1 | -3 | N/A | -2 | N/A |
6/30/2016 | 0 | -3 | N/A | -3 | N/A |
3/31/2016 | 0 | -3 | N/A | -3 | N/A |
12/31/2015 | 0 | -3 | N/A | -3 | N/A |
9/30/2015 | 0 | -3 | N/A | -3 | N/A |
6/30/2015 | 1 | -3 | N/A | -2 | N/A |
3/31/2015 | 1 | -3 | N/A | -2 | N/A |
12/31/2014 | 1 | -3 | N/A | -2 | N/A |
9/30/2014 | 1 | -3 | N/A | -2 | N/A |
6/30/2014 | 2 | -2 | N/A | -2 | N/A |
3/31/2014 | 2 | -2 | N/A | -2 | N/A |
12/31/2013 | 2 | -2 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GOVX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: GOVX is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: GOVX is expected to become profitable in the next 3 years.
Revenue vs Market: GOVX's revenue (67.9% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: GOVX's revenue (67.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GOVX's Return on Equity is forecast to be high in 3 years time